Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

1,142 public trials 219 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

NCT03776123

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +21 more
Locations
  • Korea University Ansan Hospital Ansan, South Korea
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • DONG-A University Hospital (Site A) Busan, South Korea
  • DONG-A University Hospital (Site B) Busan, South Korea
View all 47 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

NCT03849118

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California, Los Angeles Campus, Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Hospital Baltimore, Maryland, United States
View all 31 locations
View Trial Details
Completed

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

NCT03097328

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

NCT04148937

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +52 more
Locations
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
View Trial Details

Related conditions